ARCHIVES

Varmus Confirmation On Fast Track, Nominee Outlines Goals For Next Year

This article is from The Cancer Letter archive.

Vol. 19 No. 44 | November 12, 1993

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Report Urges NCI: No Unfunded Mandates for Cancer Centers

October 18, 1996

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

June 19, 1998

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985